CN Patent

CN101910133A — 杂环苯基酰胺t-型钙通道拮抗剂

Assigned to Merck Sharp and Dohme LLC · Expires 2010-12-08 · 15y expired

What this patent protects

本发明涉及杂环苯基酰胺化合物，其为T-型钙通道拮抗剂，适用于治疗或预防与T-型钙通道有关的疾病和病症。本发明还涉及包含这些化合物的药用组合物以及这些化合物和组合物在预防或治疗与T-型钙通道有关的这类疾病中的用途。

USPTO Abstract

本发明涉及杂环苯基酰胺化合物，其为T-型钙通道拮抗剂，适用于治疗或预防与T-型钙通道有关的疾病和病症。本发明还涉及包含这些化合物的药用组合物以及这些化合物和组合物在预防或治疗与T-型钙通道有关的这类疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101910133A
Jurisdiction
CN
Classification
—
Expires
2010-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.